お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
1005151

治療用BCGワクチンの世界市場:タイプ別(免疫BCG、治療用BCG)、人口動態(成人、小児)、エンドユーザー別の予測(2026年まで)- COVID-19の累積的影響

Therapeutic BCG Vaccine Market Research Report by Type, by Demographics, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 194 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.74円
治療用BCGワクチンの世界市場:タイプ別(免疫BCG、治療用BCG)、人口動態(成人、小児)、エンドユーザー別の予測(2026年まで)- COVID-19の累積的影響
出版日: 2021年06月01日
発行: 360iResearch LLP
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の治療用BCGワクチンの市場規模は、2020年の5,108万米ドルから、2025年末までに6,059万米ドルに拡大すると予想されています。

COVID-19は、ほぼすべての業界に影響を与えた未曾有の世界の公衆衛生上の緊急事態であるため、予測期間中に業界の成長に長期的な影響を与えると予測されています。当レポートでは、根底にあるCOVID-19の問題と今後の道筋を確実に扱うために、調査範囲を広げ消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場動向、および政府の重要な介入などを考慮しながら、COVID-19の影響について考察しています。

当レポートは、世界の治療用BCGワクチン市場について調査しており、市場の機会や課題、成長および抑制要因、COVID-19の累積的影響、タイプ・人口動態・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションとカバレッジ
  • 調査期間
  • 通貨と価格
  • 言語
  • 制限事項
  • 利害関係者

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査設計
    • 準備:調査機器
    • 収集:データソース
    • 分析:データの解釈
    • 策定:データ検証
    • 公開:調査レポート
    • 繰り返し:レポートの更新
  • 調査の実行
    • 開始:調査プロセス
    • 計画:調査計画を作成する
    • 実行:調査を実施する
    • 検証:発見と分析
    • 出版物:調査報告
  • 調査の成果

第3章 エグゼクティブサマリー

  • 市場の見通し
  • エンドユーザーの見通し
  • タイプ別市場の展望
  • 人口動態別市場の展望
  • 地域別市場の展望
  • 競合他社の見通し

第4章 市場概要

  • COVID-19の累積的影響

第5章 市場の洞察

  • 市場力学
    • 成長要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターのファイブフォース分析

第6章 タイプ別市場

  • 免疫BCG
  • 治療用BCG

第7章 人口動態別市場

  • 成人
  • 小児

第8章 エンドユーザー別市場

  • クリニック
  • 病院

第9章 南北アメリカ市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第11章 欧州、中東・アフリカ市場

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合他社のSWOT分析
  • 競合シナリオ
    • 合併・買収
    • 契約、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 評価、認知、拡大

第13章 企業プロファイル

  • AJ Vaccines
  • China National Biotec Group
  • Green Signal Bio Pharma Pvt Ltd
  • GREENSIGNAL BIO PHARMA LIMITED
  • InterVax Ltd.
  • Japan BCG Laboratory
  • Merck & Co., Inc.
  • Sanofi Pasteur
  • Serum Institute of India Private Limited
  • Statens Serum Institut

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL THERAPEUTIC BCG VACCINE MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL THERAPEUTIC BCG VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2026
  • FIGURE 11. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY IMMUNE BCG, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY IMMUNE BCG, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY THERAPY BCG, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY THERAPY BCG, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2020 VS 2026 (%)
  • FIGURE 16. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2026
  • FIGURE 18. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ADULTS, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ADULTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY PEDIATRICS, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY PEDIATRICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2020 VS 2026 (%)
  • FIGURE 23. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2026
  • FIGURE 25. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 30. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 32. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 33. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 34. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 35. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 36. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 37. CALIFORNIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. FLORIDA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. ILLINOIS THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. NEW YORK THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. OHIO THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. PENNSYLVANIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. TEXAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 45. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 47. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. INDONESIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. MALAYSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. PHILIPPINES THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. SOUTH KOREA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. THAILAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 56. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 58. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. GLOBAL THERAPEUTIC BCG VACCINE MARKET: FPNV POSITIONING MATRIX
  • FIGURE 70. GLOBAL THERAPEUTIC BCG VACCINE MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 71. GLOBAL THERAPEUTIC BCG VACCINE MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 72. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL THERAPEUTIC BCG VACCINE MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL THERAPEUTIC BCG VACCINE MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY IMMUNE BCG, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY THERAPY BCG, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY ADULTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY PEDIATRICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY CLINICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL THERAPEUTIC BCG VACCINE MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. AMERICAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. ARGENTINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. BRAZIL THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. CANADA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. MEXICO THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. UNITED STATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. CALIFORNIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. CALIFORNIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. CALIFORNIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. FLORIDA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. FLORIDA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. FLORIDA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. ILLINOIS THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. ILLINOIS THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. ILLINOIS THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. NEW YORK THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. NEW YORK THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. NEW YORK THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. OHIO THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. OHIO THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. OHIO THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. PENNSYLVANIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. PENNSYLVANIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. PENNSYLVANIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. TEXAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. TEXAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. TEXAS THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. ASIA-PACIFIC THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. CHINA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. INDIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. INDONESIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. INDONESIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. INDONESIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. JAPAN THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. MALAYSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. MALAYSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. MALAYSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. PHILIPPINES THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. PHILIPPINES THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. PHILIPPINES THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. SOUTH KOREA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. SOUTH KOREA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. SOUTH KOREA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. THAILAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. THAILAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. THAILAND THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. FRANCE THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. GERMANY THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. ITALY THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. NETHERLANDS THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. QATAR THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. RUSSIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. SAUDI ARABIA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. SOUTH AFRICA THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. SPAIN THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. UNITED ARAB EMIRATES THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. UNITED KINGDOM THERAPEUTIC BCG VACCINE MARKET SIZE, BY DEMOGRAPHICS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. GLOBAL THERAPEUTIC BCG VACCINE MARKET: SCORES
  • TABLE 119. GLOBAL THERAPEUTIC BCG VACCINE MARKET: BUSINESS STRATEGY
  • TABLE 120. GLOBAL THERAPEUTIC BCG VACCINE MARKET: PRODUCT SATISFACTION
  • TABLE 121. GLOBAL THERAPEUTIC BCG VACCINE MARKET: RANKING
  • TABLE 122. GLOBAL THERAPEUTIC BCG VACCINE MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 123. GLOBAL THERAPEUTIC BCG VACCINE MARKET: SHARE, BY COMPANY, 2020
  • TABLE 124. GLOBAL THERAPEUTIC BCG VACCINE MARKET: MERGER & ACQUISITION
  • TABLE 125. GLOBAL THERAPEUTIC BCG VACCINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 126. GLOBAL THERAPEUTIC BCG VACCINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 127. GLOBAL THERAPEUTIC BCG VACCINE MARKET: INVESTMENT & FUNDING
  • TABLE 128. GLOBAL THERAPEUTIC BCG VACCINE MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 129. GLOBAL THERAPEUTIC BCG VACCINE MARKET: LICENSE & PRICING
  • TABLE 130. GLOBAL THERAPEUTIC BCG VACCINE MARKET: CONTACT DETAILS
目次
Product Code: MRR-030298DFF713

The Global Therapeutic BCG Vaccine Market size was estimated at USD 51.08 Million in 2020 and expected to reach USD 53.11 Million in 2021, at a Compound Annual Growth Rate (CAGR) 4.31% to reach USD 65.80 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Therapeutic BCG Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the Therapeutic BCG Vaccine Market was studied across Immune BCG and Therapy BCG.

Based on Demographics, the Therapeutic BCG Vaccine Market was studied across Adults and Pediatrics.

Based on End User, the Therapeutic BCG Vaccine Market was studied across Clinics and Hospitals.

Based on Geography, the Therapeutic BCG Vaccine Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Therapeutic BCG Vaccine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Therapeutic BCG Vaccine Market, including AJ Vaccines, China National Biotec Group, Green Signal Bio Pharma Pvt Ltd, GREENSIGNAL BIO PHARMA LIMITED, InterVax Ltd., Japan BCG Laboratory, Merck & Co., Inc., Sanofi Pasteur, Serum Institute of India Private Limited, and Statens Serum Institut.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Therapeutic BCG Vaccine Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Therapeutic BCG Vaccine Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Therapeutic BCG Vaccine Market?
  • 4. What is the competitive strategic window for opportunities in the Global Therapeutic BCG Vaccine Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Therapeutic BCG Vaccine Market?
  • 6. What is the market share of the leading vendors in the Global Therapeutic BCG Vaccine Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Therapeutic BCG Vaccine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. End User Outlook
  • 3.4. Type Outlook
  • 3.5. Demographics Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing advancement in the pediatric care
      • 5.1.1.2. High investment in research & development of therapeutic BCG vaccine
      • 5.1.1.3. Increasing awareness through campaign
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of therapeutic BCG vaccine
    • 5.1.3. Opportunities
      • 5.1.3.1. Untapped market in developing and underdeveloped countries
      • 5.1.3.2. Growing initiatives by United Nations (UN) for TB preventions
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects associated with BCG vaccine
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Therapeutic BCG Vaccine Market, by Type

  • 6.1. Introduction
  • 6.2. Immune BCG
  • 6.3. Therapy BCG

7. Therapeutic BCG Vaccine Market, by Demographics

  • 7.1. Introduction
  • 7.2. Adults
  • 7.3. Pediatrics

8. Therapeutic BCG Vaccine Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospitals

9. Americas Therapeutic BCG Vaccine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Therapeutic BCG Vaccine Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Therapeutic BCG Vaccine Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. AJ Vaccines
  • 13.2. China National Biotec Group
  • 13.3. Green Signal Bio Pharma Pvt Ltd
  • 13.4. GREENSIGNAL BIO PHARMA LIMITED
  • 13.5. InterVax Ltd.
  • 13.6. Japan BCG Laboratory
  • 13.7. Merck & Co., Inc.
  • 13.8. Sanofi Pasteur
  • 13.9. Serum Institute of India Private Limited
  • 13.10. Statens Serum Institut

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.